Ann Neurol
- MONTINI F, Pittock SJ, Cacciaguerra L, Weiner HL, et al
Reframing the Gut-Brain Axis: The Gut Wall as a Neural Immune Interface in
Multiple Sclerosis and Autoimmune Neurological Diseases.
Ann Neurol. 2026 Sep 26. doi: 10.1002/ana.78380.
BMC Neurol
- SHARIFF S, Mairajuddin SI, Kamran SH, Al Madani AS, et al
Complex vasculitic overlap: temporal arteritis complicating suspected
neuro-behcet disease with recurrent ischemic injury.
BMC Neurol. 2026 Jul 6. doi: 10.1186/s12883-026-05120.
Curr Opin Immunol
- MERONI PL
Editorial overview: Editorial introduction - Anti-phospholipid antibody syndrome
(2025).
Curr Opin Immunol. 2026;103:102850.
- MOUTSOPOULOS HM
Autoimmune diseases: distinct disorders or diverse manifestations of a common
pathogenic process?
Curr Opin Immunol. 2026;103:102852.
Intern Med
- YOSHIDA S, Nakagomi D, Ueda M, Asahina K, et al
Biopsy-proven Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic
Antibody-associated Vasculitis Overlap Syndrome Developed during Propylthiouracil
Therapy: A Case-based Review.
Intern Med. 2026 Sep 29. doi: 10.2169/internalmedicine.7792.
- NAKAMURA S, Yamada K, Yaguchi H, Kudo A, et al
Immune Checkpoint Inhibitor Therapy Triggers Autoimmune Cerebellar Ataxia with
Anti-P/Q-type VGCC Antibody and Anti-mGluR5 Antibodies: A Case Report.
Intern Med. 2026 Sep 29. doi: 10.2169/internalmedicine.7680.
J Nephrol
- YANG C, Chen P, Xiong J
Finerenone in IgA nephropathy: A Systematic Review of Real-world Studies.
J Nephrol. 2026 Sep 30:aajag228. doi: 10.1093.
J Neuroimmunol
- ZHOU J, Zhou L, Song K, Li B, et al
Early molecular changes in the subfornical organ during experimental autoimmune
encephalomyelitis.
J Neuroimmunol. 2026;421:579103.
J Neurol
- KOREN TJ, Dugal J, Wang D, Beadnall H, et al
Spinal cord imaging in multiple sclerosis: from diagnosis to disease progression.
J Neurol. 2026;273:634.
- NICOLELLA V, Polito C, Criscuolo V, Varelli M, et al
Evaluating the neurofilament light chain-derived gap between biological and
chronological age in multiple sclerosis and controls.
J Neurol. 2026;273:625.
- STAMENKOVIC M, Vukovic I, Milosevic E, Peric S, et al
The role of leukocyte p38 MAP kinase in immune-mediated peripheral
polyneuropathies: distinct modulation by intravenous immunoglobulins.
J Neurol. 2026;273:627.
- HEDSTROM AK, Olsson T, Alfredsson L
Family history of multiple sclerosis and long-term outcomes.
J Neurol. 2026;273:622.
- GUO Q, Olsson T, Alfredsson L, Hedstrom AK, et al
Leisure-time physical activity, sun exposure, and multiple sclerosis risk: a
population-based case-control study.
J Neurol. 2026;273:623.
J Rheumatol
- NARBERHAUS HM, Tatsis S, Klotsche J, Foeldvari I, et al
Clinical Correlates of a Successful Transition in Pediatric Rheumatology.
J Rheumatol. 2026;53:1135-1139.
- ARBIV OA, Fidler L, Johnson SR, Gershon AS, et al
Management of Antineutrophil Cytoplasmic Antibody-Associated Alveolar Hemorrhage:
A Bayesian Reanalysis of the PEXIVAS Trial.
J Rheumatol. 2026;53:1117-1124.
- OLIVER M, Mosesso K, Weiss PF, Colbert RA, et al
Clinical Disease Manifestations Associated With Tumor Necrosis Factor Inhibitor
Nonresponse in Juvenile Spondyloarthritis.
J Rheumatol. 2026;53:1140-1146.
- ABOUL-HASSAN D, Alawamleh A, Mahajan N, Bailey B, et al
Qualitative Analysis of Physical Activity Engagement in Women With Self-Reported
Systemic Lupus Erythematosus: The Role of Symptoms, Healthcare Providers, and the
Environment.
J Rheumatol. 2026;53:1098-1108.
Kidney Int
- YAP DYH, Navarra SV, Ni Z, Avihingsanon Y, et al
Prospective 96-week study to evaluate efficacy and safety of tacrolimus and
glucocorticoid against mycophenolate and glucocorticoid as continuous
induction-maintenance treatment for Class III/IV without or with Class V lupus
nephritis.
Kidney Int. 2026 Sep 28:S0085-2538(26)00817-3. doi: 10.1016/j.kint.2026.
Mult Scler
- MARRIE RA, Bolton JM, Ling V, Bernstein CN, et al
Peripartum mental illness in serial pregnancies in mothers with multiple
sclerosis and other chronic diseases.
Mult Scler. 2026 Sep 30:13524585261486779. doi: 10.1177/13524585261486779.
- KUHARIC M, Nowinski C, Perschon CR, Miller CH, et al
Use of patient reported outcomes in multiple sclerosis clinical management:
Scoping literature review.
Mult Scler. 2026 Sep 29:13524585261481124. doi: 10.1177/13524585261481124.
- SCHOENHOLZER K, Sellathurai S, Burguet Villena F, Cerda-Fuertes N, et al
Retinal vessel diameters in multiple sclerosis: associations with disability,
cardiovascular risk factors and retinal atrophy.
Mult Scler. 2026 Sep 28:13524585261489425. doi: 10.1177/13524585261489425.
N Engl J Med
- DELLA-TORRE E, Baker MC, Zhang W, Perugino CA, et al
Obexelimab for the Treatment of IgG4-Related Disease.
N Engl J Med. 2026;395:1273-1284.
Neurology
- BARTER KM, Thant A, Pitt M, Thotakura V, et al
Pearls & Oy-sters: Diagnosis of Pediatric Tumefactive Multiple Sclerosis With MRI
Biomarkers.
Neurology. 2026;107:e218575.
- JAIN K, Storelli L, Valsasina P, Preziosa P, et al
Disentangling Age-Related and Disease-Specific Effects on Upper Cervical Cord
Area in Patients With Multiple Sclerosis.
Neurology. 2026;107:e218517.
- VRENKEN H
Separating Disease Effects From Aging in Spinal Cord Atrophy in Multiple
Sclerosis.
Neurology. 2026;107:e218605.
PLoS Comput Biol
- YANG C, Liao Y, Sheng Y, Jiao F, et al
Integrating zero-inflation correction and transcriptional kinetics for
single-cell transcriptomic analysis.
PLoS Comput Biol. 2026;22:e1014779.
Proc Natl Acad Sci U S A
- BAIER S, Wang Z, Loll N, Mader S, et al
T-B interactions yield CD3(+) B cells and CD20(+) T cells with pathogenic
features in multiple sclerosis.
Proc Natl Acad Sci U S A. 2026;123:e2605806123.
- VIETZEN H, Waubant EL, Casper TC, Benson LA, et al
Impaired control of autoimmunity increases pediatric multiple sclerosis risk in
EBNA-1-seropositives and -seronegatives.
Proc Natl Acad Sci U S A. 2026;123:e2607529123.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016